We rigorously follow a clear strategy to deliver on our long-term vision
To build a leading vaccine technology biotech company developing game changing medicine across an expanding range of therapeutic areas.
To achieve our vision, we follow a three-pillared strategy:
1. Accelerate and expand our pipeline
We will focus on maturing and accelerating our development projects within oncology and infectious diseases and also work to bring additional ideas from research through to the clinic.
2. Further leverage our technology platform
Embracing the unlimited potential of our modular platform technology, we will explore opportunities for expanding into new therapeutic areas like autoimmunity as well as developing novel therapeutic modalities.
3. Seek strategic, selective and value-creating partnerships
Our carefully selected collaborative partners are invaluable in accelerating the full commercial potential of our technology platform and products. We will continue to explore highly selective value-creating partnerships.